EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
1.14.11.18 | 2-hydroxyphytanoyl-CoA | - |
Homo sapiens |
EC Number | Application | Comment | Organism |
---|---|---|---|
1.14.11.18 | medicine | treatment of Refsum disease | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.14.11.18 | expressed in Escherichia coli | Homo sapiens |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
1.14.11.18 | hanging drop vapour diffusion method in 21% polyethylene glycol 3350, 0.3 M triammonium citrate, pH 7.1, at 18°C | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.14.11.18 | E197Q | disruption of the 2-oxoglutarate binding pocket | Homo sapiens |
1.14.11.18 | F275S | places a polar side chain in a hydrophobic pocket and possibly interferes with the overall structure or impair protein folding | Homo sapiens |
1.14.11.18 | G204S | disruption of the 2-oxoglutarate binding pocket, uncouples 2-oxoglutarate and phytanoyl-CoA oxidation | Homo sapiens |
1.14.11.18 | H259A | mutation removes two of the hydrogen bonds and probably destabilizes the beta-turn, which in turn destabilizes the core double stranded beta-helix | Homo sapiens |
1.14.11.18 | I199F | disruption of the 2-oxoglutarate binding pocket | Homo sapiens |
1.14.11.18 | N269H | disruption of the 2-oxoglutarate binding pocket, uncouples 2-oxoglutarate and phytanoyl-CoA oxidation | Homo sapiens |
1.14.11.18 | N83Y | disruption of protein-protein interactions proposed to involve PAHX, such as that with sterol carrier protein-2, proposed to be responsible for solubilization and presentation of phytanoyl-CoA to PAHX | Homo sapiens |
1.14.11.18 | R245Q | disruption of protein-protein interactions proposed to involve PAHX, such as that with sterol carrier protein-2, proposed to be responsible for solubilization and presentation of phytanoyl-CoA to PAHX | Homo sapiens |
1.14.11.18 | R275Q | very low catalytic activity | Homo sapiens |
1.14.11.18 | R275W | very low catalytic activity | Homo sapiens |
1.14.11.18 | W193R | disruption of the 2-oxoglutarate binding pocket | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
1.14.11.18 | peroxisome | - |
Homo sapiens | 5777 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
1.14.11.18 | Fe2+ | - |
Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
1.14.11.18 | 35440 | - |
calculated from amino acid sequence without N-terminal methionine | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.11.18 | Homo sapiens | O14832 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.14.11.18 | carboxymethyl-Sepharose cation exchange chromatography and Superdex S75 gel filtration | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.11.18 | isovaleryl-CoA + 2-oxoglutarate + O2 | - |
Homo sapiens | ? | - |
? | |
1.14.11.18 | phytanoyl-CoA + 2-oxoglutarate + O2 | - |
Homo sapiens | 2-hydroxyphytanoyl-CoA + succinate + CO2 | - |
ir |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.11.18 | PAHX | - |
Homo sapiens |
1.14.11.18 | phytanoyl-CoA 2-hydroxylase | - |
Homo sapiens |